KindlyMD, Inc. (NASDAQ:NAKA) Given Average Recommendation of “Hold” by Analysts

KindlyMD, Inc. (NASDAQ:NAKAGet Free Report) has been given an average rating of “Hold” by the five ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $30.00.

Several brokerages have commented on NAKA. Wall Street Zen upgraded shares of KindlyMD to a “sell” rating in a research note on Saturday, May 23rd. TD Cowen started coverage on shares of KindlyMD in a research report on Friday, April 10th. They set a “buy” rating and a $40.00 target price on the stock. Weiss Ratings upgraded shares of KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. Finally, Maxim Group lowered their price objective on shares of KindlyMD from $60.00 to $30.00 and set a “buy” rating on the stock in a research report on Monday, April 6th.

View Our Latest Stock Report on NAKA

Insider Activity at KindlyMD

In related news, CEO David F. Bailey bought 55,115 shares of the firm’s stock in a transaction on Thursday, May 28th. The shares were bought at an average cost of $5.62 per share, for a total transaction of $309,746.30. Following the transaction, the chief executive officer owned 3,175,476 shares of the company’s stock, valued at approximately $17,846,175.12. This trade represents a 1.77% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. In the last 90 days, insiders have acquired 191,448 shares of company stock worth $992,908. 24.49% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Osaic Holdings Inc. acquired a new position in KindlyMD in the 2nd quarter valued at about $215,000. Dynamic Technology Lab Private Ltd acquired a new position in KindlyMD in the 3rd quarter valued at about $369,000. Geode Capital Management LLC raised its stake in KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock valued at $484,000 after purchasing an additional 8,386 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of KindlyMD by 1,638.4% during the 3rd quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company’s stock valued at $827,000 after acquiring an additional 31,245 shares during the last quarter. Finally, CI Investments Inc. acquired a new position in shares of KindlyMD during the 3rd quarter valued at about $995,000.

KindlyMD Stock Performance

Shares of NAKA opened at $3.91 on Wednesday. The stock has a market capitalization of $68.03 million, a PE ratio of -0.09 and a beta of 15.84. KindlyMD has a 1 year low of $3.89 and a 1 year high of $659.20. The company’s 50-day simple moving average is $6.58 and its 200-day simple moving average is $10.86.

KindlyMD (NASDAQ:NAKAGet Free Report) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.38) earnings per share (EPS) for the quarter. The business had revenue of $2.68 million for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%. On average, sell-side analysts predict that KindlyMD will post -16.8 earnings per share for the current year.

About KindlyMD

(Get Free Report)

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.

Further Reading

Analyst Recommendations for KindlyMD (NASDAQ:NAKA)

Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.